Kaletra 100 mg (Ritonavir SOLUTION) 100 MG

KALETRA 100 MG oral solution is a medication used to manage certain viral infections. This solution contains ritonavir and is manufactured by AbbVie Corporation in Canada.

Strength

100 MG

Pack Size

160ML

Manufacturer / TM Owner

ABBVIE CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

KALETRA 100 MG oral solution is primarily used as part of combination therapy to treat viral infections. Ritonavir, the active ingredient, is often used in conjunction with other antiviral medications to manage these conditions. The solution is designed for oral administration and is typically prescribed by healthcare professionals to support treatment regimens.

Side Effects

Common effects of KALETRA 100 MG oral solution may include gastrointestinal discomfort, taste alterations, and mild dizziness. Some individuals may experience changes in bowel movements or mild headaches. These effects can vary among users and are not exhaustive.

Precautions & Warnings

KALETRA 100 MG oral solution should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Store the solution at room temperature and keep it out of reach of children. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

KALETRA 100 MG oral solution may interact with certain medications, including other antiviral drugs, CYP inhibitors, and some over-the-counter medications. Alcohol consumption should be avoided while using this solution. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

KALETRA 100 MG oral solution is used as part of combination therapy to manage certain viral infections.

KALETRA 100 MG oral solution is designed for oral administration. Follow the dosage and administration instructions provided by your healthcare professional.

Common effects may include gastrointestinal discomfort, taste alterations, and mild dizziness.

KALETRA 100 MG oral solution may interact with certain medications. Always consult your healthcare provider before combining it with other drugs.

KALETRA 100 MG oral solution can be purchased from authorized pharmacies and online retailers.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.